Monoclonal antibodies selective for prostate cancer and diagnost

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5303888, 5303897, 5303913, 43524027, 4351722, 435 7021, G01N 3353, C07K 1528, C12N 520

Patent

active

051770008

ABSTRACT:
Four monoclonal antibodies are found which selectively identify prostate cancer. These monoclonals are therefore useful in diagnosis and differential diagnosis of prostate cancer.

REFERENCES:
Frankel et al. PNAS 79: 903-907, 1982.
Houghton et al. Seminars in Oncology 13(2): 165-179, Jun. 1986.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibodies selective for prostate cancer and diagnost does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies selective for prostate cancer and diagnost, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies selective for prostate cancer and diagnost will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2390342

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.